top
Search terms
Results 1 - 5 of 5 - ordered by :
Ehjcvp

Introduction While rates of death due to cardiovascular diseases have declined over the past decades in both the USA and Europe, the attributable burden remains high.1,2 Among these, acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, J. Wouter Jukema, Maddalena Lettino, Petr Widimský, Nicolas Danchin, Alfredo Bardaji, Jose A. Barrabes, Angel Cequier, ...

Date : 01/10/2015 Item size : 496391 bytes
Ehjcvp

In this issue of the journal, Jørgensen and co-workers report temporal changes in patient characteristics and pharmacotherapy in 156 496 patients referred for coronary angiography between 2000 and ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/07/2015 Item size : 94363 bytes
Ehjcvp

In this issue of European Heart Journal Cardiovascular Pharmacology a substudy of the Italian EYESHOT Registry focused on medically managed patients is published.1 In it, the authors describe the ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Héctor Bueno

Date : 01/07/2015 Item size : 219771 bytes
Ehjcvp

While the absolute number of comorbidities such as renal disease, liver disease, chronic obstructive pulmonary disease, and vascular disease has increased, there was a relative decrease of ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Lorenz Koller, Alexander Niessner

Date : 01/07/2015
Ehjcvp

At age 40, the associated lifetime risk of developing coronary heart disease is 48.6% among men and 31.7% among women.1 Despite advances in the field of non-invasive coronary artery testing and ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Mads E. Jørgensen, Charlotte Andersson, Anne-Marie Schjerning Olsen, Knud Juel, Poul Erik Mortensen, Erik Jørgensen, ...

Date : 01/07/2015